Affimed and Roivant Sciences Announce Licensing and Strategic Collaboration Agreement to Develop and Commercialize Novel Innate Cell Engagers (ICE® ) for Multiple Cancer Targets
November 9, 2020
November 9, 2020
November 9, 2020
November 5, 2020
November 4, 2020
November 4, 2020
November 3, 2020
October 20, 2020
October 14, 2020
October 6, 2020
September 29, 2020